Biofusion owns the rights to 100% of the university-owned research generated at two of the UK's leading universities – The University of Sheffield and Cardiff University. These exclusive partnerships enable us to invest in some the world's most advanced and exciting science, turning world class research into business through the creation of a growing portfolio of companies, in fields as varied as drug discovery, alternative energy and engineering.
Delivering for shareholders
We own the rights to an amazing depth and quality of research and we aim to turn that into real value for our shareholders. Our combination of short, medium and long term investments minimises risk and offers the potential for significant value growth for our shareholders.
As shareholders in Biofusion, our partner universities are rewarded and incentivised to ensure that their R&D spend is focused on generating world class IP and the academics are rewarded with shareholdings in the subsequent portfolio companies.
Partnering universities
In 2005, we signed an exclusive 10 year agreement with The University of Sheffield, the UK’s 5th ranked University for the quality of its life science IP, focusing on biosciences and commercialising all of their owned medical IP.
In 2007 we signed a second exclusive 10 year agreement with Cardiff University, the UK’s 5th ranked University for the overall quality of its IP, to commercialise all of their IP.
These partnerships allow everyone to play to their strengths – our partners focus on creation and innovation, and we take care of commercialisation. At the point of cross-over we are well integrated with each university’s existing technology transfer team, ensuring that progress is smooth and seamless.